Litcius/Paper detail

Variation in the expression level of MALAT1, MIAT and XIST lncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus

Nasim Sohrabifar, Sayyed Mohammad Hossein Ghaderian, Saeed Alipour Parsa, Hamid Ghaedi, Hossein Jafari

2020Archives of Physiology and Biochemistry45 citationsDOI

Abstract

Background: The MALAT1, MIAT, and XIST long noncoding RNAs (lncRNAs) participate in the pathogenesis of complex diseases and also serve as diagnostic markers. The study aimed to assess their expressions in CAD patients with or without T2DM against diabetic and non-diabetic controls.Methods: The expression levels of three lncRNAs in 50 CAD patients (with or without diabetes) and 50 non-CAD subjects (with or without diabetes) were evaluated by using the TaqMan Assay method.Results: MALAT1 and MIAT were upregulated in CAD patients (p Value= .0008 and .0078, respectively). The expression level of XIST was significantly elevated diabetic compared to non-diabetic CAD patients (p Value= .0003). MALAT1 gene had the highest diagnostic power for discrimination of CAD patients from controls (AUC= 0.682, p Value=.001).Conclusions: The current study supports the participation of lncRNAs in the pathogenesis of CAD and T2DM and highlights their potential as diagnostic biomarkers.

Topics & Concepts

MALAT1XISTPathogenesisCoronary artery diseaseLong non-coding RNADiabetes mellitusCADMedicineInternal medicineDiseaseDownregulation and upregulationBiologyEndocrinologyGastroenterologyOncologyGeneGeneticsX chromosomeX-inactivationBiochemistryCancer-related molecular mechanisms researchCircular RNAs in diseasesRNA modifications and cancer